436 research outputs found

    ANÁLISE DO MANEJO AGUDO DO ACIDENTE VASCULAR CEREBRAL NO HOSPITAL DE CLÍNICAS DE PORTO ALEGRE

    Get PDF
    Introdução: Acidente vascular cerebral (AVC) é a segunda causa de óbito no mundo e a terceira nos países industrializados. O objetivo deste estudo é avaliar a qualidade do atendimento prestado aos pacientes vítimas de AVC no Hospital de Clínicas de Porto Alegre (HCPA). Poucos trabalhos descrevem o modo de atendimento ideal do AVC agudo, e a ausência de padronização de condutas muitas vezes implica em retardo diagnóstico e terapêutico. Materiais e métodos: trabalho retrospectivo onde foram analisados 55 pacientes (n: 55) admitidos na emergência do HCPA com diagnóstico de AVC agudo, através de suas características demográficas (sexo e idade), tempo de internação e mortalidade geral, indicadores de atendimento inicial (glicemia capilar [GC], pressão arterial [PA], perfil lipídico, eletrocardiograma [ECG], tomografia computadorizada [TC] de crânio), avaliação complementar (ecocardiograma,ecografia com doppler de carótidas, tomografia após 48 horas) e tratamento instituído (AAS, estatina, anticoagulação, trombolítico). Resultados: dos 55 pacientes, 45 (81,8%) apresentaram diagnóstico de AVC isquêmico e10 (18,2%) de AVC hemorrágico, sendo que a mortalidade do AVC hemorrágico foi significativamente maior (40% vs 4%). Mais de 90% obtiveram medidas de PA e ECG na chegada, e 100% dos pacientes realizaram TC de crânio nas primeiras 24 horas; medidas de GC foram feitas em 60% dos pacientes, e perfil lipídico em apenas 11%. Dos exames complementares destaca-se o ecocardiograma realizado em quase 90% dos casos (69% transtorácico e 18%transesofágico [TE]) e a ecodoppler de carótidas feita em 90%; menos de 30% dos pacientes obtiveram TC após 48 horas. Quanto ao tratamento, aproximadamente 80% receberam AAS e estatina; 20% receberam anticoagulação e nenhum recebeu trombolítico. As análises dos examescomplementares e do tratamento foram realizadas apenas nos pacientes com AVC isquêmico. Discussão: a análise dos dados demográficos e a caracterização do AVC (hemorrágico X isquêmico) foram similares aos encontrados na literatura. A falha do estudo foi não ter excluído os pacientes que foram a óbito na análise do tempo de internação, desta forma subestimando o resultado principalmente do AVC hemorrágico, que obteve maior mortalidade. A avaliaçãocomplementar foi satisfatória e condizente com a descrição da literatura. Quanto ao tratamento, apesar de fortes evidências validando o uso de trombolíticos, este não foi praticado neste hospital por norma interna do serviço; a prescrição de AAS e estatina foi adequada ao recomendado na literatura.Unitermos: acidente vascular cerebral; AVC; manejo agudo; indicadores assistenciais

    Interleukin-18 Is a Potential Biomarker Linking Dietary Fatty Acid Quality and Insulin Resistance: Results from a Cross-Sectional Study in Northern Italy

    Get PDF
    Dietary lipids are pivotal in modulating metabolic inflammation. Among the inflammatory mediators characterizing metabolic inflammation, interleukin 18 (IL-18) has been consistently associated with obesity and insulin resistance. This study aims to evaluate whether the quality of lipid intake impacts upon IL-18 plasma levels and the implications on insulin resistance computed by the homeostatic model assessment for insulin resistance (HOMA-IR). Using a cross-sectional design, this study confirmed that IL-18 correlated positively with insulin resistance and individuals with a HOMA-IR ≥ 2.5 displayed higher circulating IL-18 levels compared with their insulin-sensitive counterparts. In terms of the effect of the quality of dietary lipids on IL-18 circulating levels, the ratio between monounsaturated, omega-3, polyunsaturated and saturated fatty acids as well as the intake of eicosapentaenoic and docosahexaenoic acids correlated negatively with IL-18. Despite this, IL-18 circulating levels, but not dietary fatty acid quality, predicted insulin resistance. Nevertheless, the ratio between omega 3 and saturated fatty acids was a predictor of IL-18 plasma levels. Thus, the downregulation of IL-18 may underpin, at least partially, the beneficial metabolic effects of substituting omega 3 for saturated fatty acids with this cytokine potentially representing a biomarker linking dietary lipids and metabolic outcomes

    Irisin Attenuates Muscle Impairment during Bed Rest through Muscle-Adipose Tissue Crosstalk

    Get PDF
    The detrimental effect of physical inactivity on muscle characteristics are well known. Irisin, an exercise-induced myokine cleaved from membrane protein fibronectin type III domain-containing protein-5 (FNDC5), mediates at least partially the metabolic benefits of exercise. This study aimed to assess the interplay between prolonged inactivity, circulating irisin, muscle performance, muscle fibers characteristics, as well as the FNDC5 gene expression (FNDC5ge) in muscle and adipose tissue among healthy subjects. Twenty-three healthy volunteers were tested before and after 14 days of Bed Rest, (BR). Post-BR circulating levels of irisin significantly increased, whereas body composition, muscle performance, and muscle fiber characteristics deteriorated. Among the subjects achieving the highest post-BR increase of irisin, the lowest reduction in maximal voluntary contraction and specific force of Fiber Slow/1, the highest increase of FNDC5ge in adipose tissue, and no variation of FNDC5ge in skeletal muscle were recorded. Subjects who had the highest FNDC5ge in adipose tissue but not in muscle tissue showed the highest circulating irisin levels and could better withstand the harmful effect of BR

    Sarcopenia parameters in active older adults - an eight-year longitudinal study

    Get PDF
    BACKGROUD: Sarcopenia is a common skeletal muscle syndrome that is common in older adults but can be mitigated by adequate and regular physical activity. The development and severity of sarcopenia is favored by several factors, the most influential of which are a sedentary lifestyle and physical inactivity. The aim of this observational longitudinal cohort study was to evaluate changes in sarcopenia parameters, based on the EWGSOP2 definition in a population of active older adults after eight years. It was hypothesized that selected active older adults would perform better on sarcopenia tests than the average population. METHODS: The 52 active older adults (22 men and 30 women, mean age: 68.4 ± 5.6 years at the time of their first evaluation) participated in the study at two time points eight-years apart. Three sarcopenia parameters were assessed at both time points: Muscle strength (handgrip test), skeletal muscle mass index, and physical performance (gait speed), these parameters were used to diagnose sarcop0enia according to the EWGSOP2 definition. Additional motor tests were also performed at follow-up measurements to assess participants' overall fitness. Participants self-reported physical activity and sedentary behavior using General Physical Activity Questionnaire at baseline and at follow-up measurements. RESULTS: In the first measurements we did not detect signs of sarcopenia in any individual, but after 8 years, we detected signs of sarcopenia in 7 participants. After eight years, we detected decline in ; muscle strength (-10.2%; p < .001), muscle mass index (-5.4%; p < .001), and physical performance measured with gait speed (-28.6%; p < .001). Similarly, self-reported physical activity and sedentary behavior declined, too (-25.0%; p = .030 and - 48.5%; p < .001, respectively). CONCLUSIONS: Despite expected lower scores on tests of sarcopenia parameters due to age-related decline, participants performed better on motor tests than reported in similar studies. Nevertheless, the prevalence of sarcopenia was consistent with most of the published literature. TRIAL REGISTRATION: The clinical trial protocol was registered on ClinicalTrials.gov, identifier: NCT04899531

    ESPEN guidelines on definitions and terminology of clinical nutrition

    Get PDF
    BACKGROUND: A lack of agreement on definitions and terminology used for nutrition-related concepts and procedures limits the development of clinical nutrition practice and research. OBJECTIVE: This initiative aimed to reach a consensus for terminology for core nutritional concepts and procedures. METHODS: The European Society of Clinical Nutrition and Metabolism (ESPEN) appointed a consensus group of clinical scientists to perform a modified Delphi process that encompassed e-mail communication, face-to-face meetings, in-group ballots and an electronic ESPEN membership Delphi round. RESULTS: Five key areas related to clinical nutrition were identified: concepts; procedures; organisation; delivery; and products. One core concept of clinical nutrition is malnutrition/undernutrition, which includes disease-related malnutrition (DRM) with (eq. cachexia) and without inflammation, and malnutrition/undernutrition without disease, e.g. hunger-related malnutrition. Over-nutrition (overweight and obesity) is another core concept. Sarcopenia and frailty were agreed to be separate conditions often associated with malnutrition. Examples of nutritional procedures identified include screening for subjects at nutritional risk followed by a complete nutritional assessment. Hospital and care facility catering are the basic organizational forms for providing nutrition. Oral nutritional supplementation is the preferred way of nutrition therapy but if inadequate then other forms of medical nutrition therapy, i.e. enteral tube feeding and parenteral (intravenous) nutrition, becomes the major way of nutrient delivery. CONCLUSION: An agreement of basic nutritional terminology to be used in clinical practice, research, and the ESPEN guideline developments has been established. This terminology consensus may help to support future global consensus efforts and updates of classification systems such as the International Classification of Disease (ICD). The continuous growth of knowledge in all areas addressed in this statement will provide the foundation for future revisions

    A Network-Based Approach to Prioritize Results from Genome-Wide Association Studies

    Get PDF
    Genome-wide association studies (GWAS) are a valuable approach to understanding the genetic basis of complex traits. One of the challenges of GWAS is the translation of genetic association results into biological hypotheses suitable for further investigation in the laboratory. To address this challenge, we introduce Network Interface Miner for Multigenic Interactions (NIMMI), a network-based method that combines GWAS data with human protein-protein interaction data (PPI). NIMMI builds biological networks weighted by connectivity, which is estimated by use of a modification of the Google PageRank algorithm. These weights are then combined with genetic association p-values derived from GWAS, producing what we call ‘trait prioritized sub-networks.’ As a proof of principle, NIMMI was tested on three GWAS datasets previously analyzed for height, a classical polygenic trait. Despite differences in sample size and ancestry, NIMMI captured 95% of the known height associated genes within the top 20% of ranked sub-networks, far better than what could be achieved by a single-locus approach. The top 2% of NIMMI height-prioritized sub-networks were significantly enriched for genes involved in transcription, signal transduction, transport, and gene expression, as well as nucleic acid, phosphate, protein, and zinc metabolism. All of these sub-networks were ranked near the top across all three height GWAS datasets we tested. We also tested NIMMI on a categorical phenotype, Crohn’s disease. NIMMI prioritized sub-networks involved in B- and T-cell receptor, chemokine, interleukin, and other pathways consistent with the known autoimmune nature of Crohn’s disease. NIMMI is a simple, user-friendly, open-source software tool that efficiently combines genetic association data with biological networks, translating GWAS findings into biological hypotheses
    corecore